These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32389765)

  • 41. Meta-analysis of Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
    Kuno T; Ueyama H; Takagi H; Ando T; Numasawa Y; Briasoulis A; Fox J; Bangalore S
    Am J Cardiol; 2020 Feb; 125(4):521-527. PubMed ID: 31839147
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Saito Y; Kobayashi Y
    J Cardiol; 2019 Jan; 73(1):1-6. PubMed ID: 30293674
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease.
    Cairns JA; McMurtry MS
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S60-70. PubMed ID: 23790600
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled Trials.
    Lopes RD; Hong H; Harskamp RE; Bhatt DL; Mehran R; Cannon CP; Granger CB; Verheugt FWA; Li J; Ten Berg JM; Sarafoff N; Gibson CM; Alexander JH
    JAMA Cardiol; 2019 Aug; 4(8):747-755. PubMed ID: 31215979
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Time trends in antithrombotic management of patients with atrial fibrillation treated with coronary stents: Results from TALENT-AF (The internAtionaL stENT - Atrial Fibrillation study) multicenter registry.
    Potter BJ; Andò G; Cimmino G; Ladeiras-Lopes R; Frikah Z; Chen XY; Virga V; Goncalves-Almeida J; Camm AJ; Fox KAA
    Clin Cardiol; 2018 Apr; 41(4):470-475. PubMed ID: 29663443
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Site Variation and Outcomes for Antithrombotic Therapy in Atrial Fibrillation Patients After Percutaneous Coronary Intervention.
    Olivier CB; Fan J; Askari M; Mahaffey KW; Heidenreich PA; Perino AC; Leef GC; Ho PM; Harrington RA; Turakhia MP
    Circ Cardiovasc Interv; 2019 Aug; 12(8):e007604. PubMed ID: 31416357
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Pharmacological strategy pre- and post-percutaneous coronary intervention in patients with acute coronary syndrome on oral anticoagulation therapy].
    Franchina AG; Capodanno D
    G Ital Cardiol (Rome); 2020 Feb; 21(2 Suppl 1):26S-33S. PubMed ID: 32134405
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is There a Role for Triple Therapy After ACS?
    Bhogal S; Alkhouli M; White CJ; Bailey S; Mamas M; Haddad E; Paul TK
    Curr Cardiol Rep; 2022 Mar; 24(3):191-200. PubMed ID: 35112242
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial.
    Kerneis M; Gibson CM; Chi G; Mehran R; AlKhalfan F; Talib U; Pahlavani S; Mir M; Bode C; Halperin JL; Nafee T; Peterson ED; Verheugt FWA; Wildgoose P; van Eickels M; Lip GYH; Fox KAA; Cohen M
    JACC Cardiovasc Interv; 2018 Apr; 11(7):626-634. PubMed ID: 29550085
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review.
    Capodanno D; Huber K; Mehran R; Lip GYH; Faxon DP; Granger CB; Vranckx P; Lopes RD; Montalescot G; Cannon CP; Ten Berg J; Gersh BJ; Bhatt DL; Angiolillo DJ
    J Am Coll Cardiol; 2019 Jul; 74(1):83-99. PubMed ID: 31272556
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Percutaneous coronary intervention and atrial fibrillation: the triple therapy dilemma.
    Cho JR; Angiolillo DJ
    J Thromb Thrombolysis; 2015 Feb; 39(2):203-8. PubMed ID: 25164314
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Advances in Antiplatelet and Anticoagulant Therapies for NSTE-ACS.
    Badjatiya A; Rao SV
    Curr Cardiol Rep; 2019 Jan; 21(1):3. PubMed ID: 30637536
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Triple, dual, and single antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Saito Y; Kobayashi Y
    Cardiovasc Interv Ther; 2020 Jan; 35(1):44-51. PubMed ID: 31281936
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dual Versus Triple Antithrombotic Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation: An Updated Meta-Analysis.
    Goel S; Pasam RT; Sharma A; Gidwani U
    Cardiovasc Revasc Med; 2020 Feb; 21(2):239-241. PubMed ID: 31718958
    [No Abstract]   [Full Text] [Related]  

  • 55. Antithrombotic regimens in patients with atrial fibrillation and coronary artery disease after percutaneous coronary intervention: A focused review.
    Chang KW; Arbit B; Hsu JC
    Int J Cardiol; 2017 Sep; 243():263-269. PubMed ID: 28595745
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Could the PARIS Risk Scores Be Useful for the Choice of Triple versus Dual Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention?
    De Luca L; Bolognese L; Rubboli A; Lucci D; Gabrielli D; Colivicchi F; Gulizia MM;
    Cardiology; 2022; 147(2):133-136. PubMed ID: 35016176
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evolving paradigms in antithrombotic therapy for anticoagulated patients undergoing coronary stenting.
    Buccheri S; Angiolillo DJ; Capodanno D
    Ther Adv Cardiovasc Dis; 2019; 13():1753944719891688. PubMed ID: 31814532
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety and Efficacy of Oral Anticoagulants Therapies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-Analysis.
    Mainka FF; Ferreira VL; Mendes AM; Marques GL; Fernandez-Llimos F; Tonin FS; Pontarolo R
    J Cardiovasc Pharmacol Ther; 2020 Sep; 25(5):399-408. PubMed ID: 32489116
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA).
    Lip GYH; Collet JP; Haude M; Byrne R; Chung EH; Fauchier L; Halvorsen S; Lau D; Lopez-Cabanillas N; Lettino M; Marin F; Obel I; Rubboli A; Storey RF; Valgimigli M; Huber K;
    Europace; 2019 Feb; 21(2):192-193. PubMed ID: 30052888
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [ANMCO Position paper: Antithrombotic treatment of patients with atrial fibrillation undergoing intracoronary stenting and/or acute coronary syndromes].
    De Luca L; Rubboli A; Lettino M; Tubaro M; Leonardi S; Casella G; Valente S; Rossini R; Sciahbasi A; Natale E; Trambaiolo P; Navazio A; Cipriani M; Corda M; De Nardo A; Francese GM; Napoletano C; Tizzani E; Roncon L; Caldarola P; Riccio C; Gabrielli D; Oliva F; Gulizia MM; Colivicchi F
    G Ital Cardiol (Rome); 2022 May; 23(5):379-395. PubMed ID: 35578959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.